A phase 1 study to evaluate the safety and LDL cholesterol-lowering effects of RG7652, a fully human monoclonal antibody against proprotein convertase subtilisin/kexin type 9.
| Image |  |
|---|---|
| Description | scientific article published on 22 March 2017 |
| Author/s |
author: Amos Baruch Daniel Kirchhofer |
| Publication date | March 22, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |